Kalaris Therapeutics, Inc.
KLRS·NasdaqGM·Healthcare
2.2600−0.1000 (−4.24%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close2.3600
Open2.3700
Day range2.22002.3700
52-week range2.220011.8800
Off day high−4.64%
Off 52-week high−80.98%
Volume122.09K
Avg. volume (3M)254.36K
Market cap53.80M
EPS (TTM)-2.02
Forward P/E-1.37
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding23.80M
Short interest3.98% of float
Earnings dateAug 7, 2025 (est.)
Analyst target18.7143
Profit margin0.00%
Against its peers
Compare in full ›| KLRS | KALA | TRDA | KPRX | EYPT | TELO | |
|---|---|---|---|---|---|---|
| Market cap | 53.80M | 5.42M | 214.15M | 11.33M | 278.35M | 80.98M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.4 | 0.0 | -1.8 | -1.1 | -1.2 | -3.9 |
| Price/book | 0.9 | 0.6 | 0.8 | 0.7 | 1.7 | 15.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −50.42% | −99.61% | −2.41% | −6.62% | −74.51% | −30.00% |
| Today | −4.24% | −4.76% | −3.00% | +0.79% | −2.35% | −1.79% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KLRS news ›KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Key HighlightsTarget generated approximately $12.7 million in revenue for the trailing twelve months ended August 2026 (unaudited, as provided by...
From articles in the 4Search news index.
In the news
1mentions in 30 days
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
-
newsfilecorp.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.